Tenon Medical (TNON) CCO gains indirect stake through SiVantage milestone grant

Rhea-AI Filing Summary

Tenon Medical, Inc. reported an equity milestone payment tied to its acquisition of assets from SiVantage, Inc. Under an Asset Purchase Agreement dated August 1, 2025, the company issued 276,228 shares of common stock to SiVantage on May 1, 2026 after a specified milestone was achieved.

The Form 4 for Chief Commercial Officer Nathaniel A. Grawey reflects his indirect pecuniary interest in these shares through his 24.69% equity interest in SiVantage, corresponding to 68,201 shares. After this award, he holds 243,584 shares indirectly via SiVantage and 239,281 shares directly of Tenon Medical common stock.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Grawey Nathaniel A.

Role Chief Commercial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common stock	68,201	$0.00	--
holding	Common stock	--	--	--

Holdings After Transaction: Common stock — 243,584 shares (Indirect, By SiVantage, Inc.); Common stock — 239,281 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares issued to SiVantage: 276,228 shares SiVantage equity interest: 24.69% Indirect pecuniary interest: 68,201 shares +2 more

5 metrics

Shares issued to SiVantage 276,228 shares Common stock issued on May 1, 2026 under Asset Purchase Agreement

SiVantage equity interest 24.69% Nathaniel Grawey’s equity interest in SiVantage, Inc.

Indirect pecuniary interest 68,201 shares Tenon Medical shares corresponding to Grawey’s interest in SiVantage

Indirect holdings after transaction 243,584 shares Tenon Medical common stock held via SiVantage reflecting Grawey’s pecuniary interest

Direct holdings 239,281 shares Tenon Medical common stock held directly by Nathaniel Grawey after the transaction

Key Terms

Asset Purchase Agreement, indirect pecuniary interest, beneficial ownership

3 terms

Asset Purchase Agreement financial

"pursuant to the Asset Purchase Agreement, dated August 1, 2025, by and between the Registrant and SiVantage"

An asset purchase agreement is a legal contract in which a buyer agrees to buy specific assets and contracts of a business rather than buying the company’s stock or ownership. It matters to investors because it determines exactly what is being bought and what liabilities stay behind — like buying the furniture and equipment from a store but not the building or past debts — which affects the deal’s value, taxes and future risk exposure.

indirect pecuniary interest financial

"The securities reported herein represent the reporting person's indirect pecuniary interest in the shares held by SiVantage"

beneficial ownership financial

"The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Grawey Nathaniel A.

(Last) (First) (Middle)

104 COOPER CT.

(Street)

LOS GATOS CALIFORNIA 95032

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Tenon Medical, Inc. [ TNON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	05/01/2026		A		68,201	A	$0	243,584	I	By SiVantage, Inc.(1)
Common stock								239,281	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On May 1, 2026, Tenon Medical, Inc. ("Registrant") issued 276,228 shares of its common stock to SiVantage, Inc. ("SiVantage") pursuant to the Asset Purchase Agreement, dated August 1, 2025, by and between the Registrant and SiVantage, in connection with the achievement of a certain milestone set forth therein. The securities reported herein represent the reporting person's indirect pecuniary interest in the shares held by SiVantage based on the reporting person's 24.69% equity interest in SiVantage. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest.

	/s/ Nathaniel Grawey	05/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What does Tenon Medical (TNON) disclose in this Form 4 for Nathaniel Grawey?

The Form 4 shows Chief Commercial Officer Nathaniel A. Grawey gaining an indirect interest in Tenon Medical shares issued to SiVantage, Inc. as a milestone payment. His interest arises through his equity stake in SiVantage, not from a direct market purchase or sale of TNON shares.

How many Tenon Medical shares were issued to SiVantage under the asset deal?

Tenon Medical issued 276,228 shares of common stock to SiVantage, Inc. on May 1, 2026. This issuance was made pursuant to an Asset Purchase Agreement dated August 1, 2025, triggered by the achievement of a defined milestone in that agreement.

How is Nathaniel Grawey’s indirect ownership in Tenon Medical shares calculated?

Nathaniel Grawey owns a 24.69% equity interest in SiVantage, Inc., which received 276,228 Tenon shares. Based on that percentage, his indirect pecuniary interest corresponds to 68,201 Tenon Medical shares. He disclaims beneficial ownership beyond the extent of this pecuniary interest.

What are Nathaniel Grawey’s Tenon Medical share holdings after this transaction?

Following the reported transaction, Nathaniel Grawey holds 239,281 Tenon Medical common shares directly. Through SiVantage, Inc., he has an indirect pecuniary interest in 243,584 shares, reflecting his equity stake in that entity rather than direct personal ownership of all those shares.

Did Nathaniel Grawey buy or sell Tenon Medical (TNON) shares on the open market?

The filing does not show any open-market purchases or sales by Nathaniel Grawey. Instead, it reports an award-type acquisition of an indirect interest via SiVantage, Inc. receiving Tenon shares as a milestone payment under an Asset Purchase Agreement.

What agreement triggered Tenon Medical’s share issuance to SiVantage?

The issuance stems from an Asset Purchase Agreement dated August 1, 2025 between Tenon Medical and SiVantage, Inc. When a certain milestone in that agreement was achieved, Tenon Medical issued 276,228 common shares to SiVantage as part of the purchase consideration.